DeviceSpace.com
Medical Device and Diagnostics
News & Jobs
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login  
 News | News By Subject | News By Date | Search News
Get Our Industry eNewsletter FREE email:    
 Print  Email    

Teva Pharmaceutical Industries Limited (TEVA) Mulling Move from Nasdaq to NYSE


3/5/2012 7:53:46 AM

After 30 years of trading on Nasdaq, Teva Pharmaceutical Industries is thinking of moving to the New York Stock Exchange. The move is probably the brainchild of Teva chairman Phillip Frost, who is associated with the NYSE and has reportedly been pitching the idea to incoming CEO Jeremy Levin, say industry insiders. In April 2005 Frost was named vice-chairman of the AMEX exchange, which the NYSE acquired in 2008. He has controlling interests in a number of NYSE-listed companies, including Ivax Corp (which Teva acquired ), biomed company Prolor, financial services company Ladenberg, alcoholic beverages maker Castle, and the pharma company Opko.

Read at HA'ARETZ

 Read Article at  Related Companies  News Categories
HA'ARETZ
   


ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 
    

//-->